Ralph Lauren tops 2Q profit forecasts
Ralph Lauren Corp. (RL) on Thursday reported fiscal second-quarter profit of $45 million.
Kohl's Profit Beats Estimates
Department store operator Kohl's reported a better-than-expected 21.7 percent jump in quarterly profit on Thursday, helped mainly by cost-cutting.
Kohl's Profit Beats Estimates
Department store operator Kohl's reported a better-than-expected 21.7 percent jump in quarterly profit on Thursday, helped mainly by cost-cutting.
Kohl's tops Street 3Q forecasts
Kohl's Corp. (KSS) on Thursday reported fiscal third-quarter earnings of $146 million.
Kohl's tops Street 3Q forecasts
Kohl's Corp. (KSS) on Thursday reported fiscal third-quarter earnings of $146 million.
Egyptian power project boosts Siemens quarterly profit
Germany's Siemens AG says revenue from a large power generation project in Egypt helped its fourth-quarter net profit rise by 18 percent.
Egyptian power project boosts Siemens quarterly profit
Germany's Siemens AG says revenue from a large power generation project in Egypt helped its fourth-quarter net profit rise by 18 percent.
Drug firm AstraZeneca says 3Q earnings fall 12 percent.
Anglo-Swedish drugmaker AstraZeneca says third-quarter earnings fell 12 percent as its blockbuster cholesterol drug Crestor faced its first full quarter of competition in the United States from generic alternatives.
Drug firm AstraZeneca says 3Q earnings fall 12 percent.
Anglo-Swedish drugmaker AstraZeneca says third-quarter earnings fell 12 percent as its blockbuster cholesterol drug Crestor faced its first full quarter of competition in the United States from generic alternatives.
Mylan sees 3Q loss due to settlement for EpiPen overcharges
Drugmaker Mylan Inc. swung to a third-quarter loss, mainly due to a big settlement for overcharging the federal government for its controversial EpiPen, the emergency allergy injector whose price Mylan has repeatedly jacked up.
Mylan sees 3Q loss due to settlement for EpiPen overcharges
Drugmaker Mylan Inc. swung to a third-quarter loss, mainly due to a big settlement for overcharging the federal government for its controversial EpiPen, the emergency allergy injector whose price Mylan has repeatedly jacked up.
Shake Shack Stock Soars As Profit Doubles
Shake Shack Inc, known for indulgent antibiotic-free hamburgers, crinkle-cut fries and frozen custard shakes, on Wednesday said profits more than doubled, sending shares up 8.1 percent in extended trading.
Shake Shack Stock Soars As Profit Doubles
Shake Shack Inc, known for indulgent antibiotic-free hamburgers, crinkle-cut fries and frozen custard shakes, on Wednesday said profits more than doubled, sending shares up 8.1 percent in extended trading.
Viacom posts 4Q profit
Viacom Inc. (VIA) on Wednesday reported fiscal fourth-quarter earnings of $254 million.
Viacom posts 4Q profit
Viacom Inc. (VIA) on Wednesday reported fiscal fourth-quarter earnings of $254 million.
Dish misses 3Q profit forecasts
Dish Network Corp. (DISH) on Wednesday reported third-quarter earnings of $307.4 million.
Dish misses 3Q profit forecasts
Dish Network Corp. (DISH) on Wednesday reported third-quarter earnings of $307.4 million.
Wendy's beats Street 3Q forecasts
Wendy's Co. (WEN) on Wednesday reported third-quarter net income of $48.9 million.
Wendy's beats Street 3Q forecasts
Wendy's Co. (WEN) on Wednesday reported third-quarter net income of $48.9 million.
Wendy's Quarterly Sales Handily Beat Estimates
U.S. burger chain Wendy's Co reported higher-than-expected quarterly sales as more diners visited its restaurants.








